Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02586207
Title	Pembrolizumab in Combination With CRT for LA-SCCHN
Recruitment	Active, not recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Sanford Health
Indications	oral squamous cell carcinoma head and neck squamous cell carcinoma laryngeal squamous cell carcinoma oropharynx cancer hypopharynx cancer
Therapies	Cisplatin + Pembrolizumab
Age Groups:	adult
Covered Countries	USA

Filter rows:

Showing 1 to 4 of 4 entries

Facility	City	State	Zip	Country	Details
Sanford Health Cancer Center	Sioux Falls	South Dakota	57104	United States	Details
Sanford-Bismarck Medical Center	Bismarck	North Dakota	58501	United States	Details
Sanford-Roger Maris Cancer Center	Fargo	North Dakota	58122	United States	Details
UCSD Moores Cancer Center	La Jolla	California	92093-0698	United States	Details

Showing 1 to 4 of 4 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field